Literature DB >> 15016851

p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.

Zohar Sachs1, Norman E Sharpless, Ronald A DePinho, Naomi Rosenberg.   

Abstract

Pre-B-cell transformation by Abelson virus (Ab-MLV) is a multistep process in which primary transformants are stimulated to proliferate but subsequently undergo crisis, a period of erratic growth marked by high levels of apoptosis. Inactivation of the p53 tumor suppressor pathway is an important step in this process and can be accomplished by mutation of p53 or down-modulation of p19(Arf), a p53 regulatory protein. Consistent with these data, pre-B cells from either p53 or Ink4a/Arf null mice bypass crisis. However, the Ink4a/Arf locus encodes both p19(Arf) and a second tumor suppressor, p16(Ink4a), that blocks cell cycle progression by inhibiting Cdk4/6. To determine if p16(Ink4a) plays a role in Ab-MLV transformation, primary transformants derived from Arf(-/-) and p16(Ink4a(-/-)) mice were compared. A fraction of those derived from Arf(-/-) animals underwent crisis, and even though all p16(Ink4a(-/-)) primary transformants experienced crisis, these cells became established more readily than cells derived from +/+ mice. Analyses of Ink4a/Arf(-/-) cells infected with a virus that expresses both v-Abl and p16(Ink4a) revealed that p16(Ink4a) expression does not alter cell cycle profiles but does increase the level of apoptosis in primary transformants. These results indicate that both products of the Ink4a/Arf locus influence Ab-MLV transformation and reveal that in addition to its well-recognized effects on the cell cycle, p16(Ink4a) can suppress transformation by inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016851      PMCID: PMC371071          DOI: 10.1128/jvi.78.7.3304-3311.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis.

Authors:  S Reid; R Cross; E C Snow
Journal:  J Immunol Methods       Date:  1996-06-10       Impact factor: 2.303

2.  Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

Authors:  D E Quelle; M Cheng; R A Ashmun; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 3.  The viral and cellular forms of the Abelson (abl) oncogene.

Authors:  N Rosenberg; O N Witte
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

4.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

5.  Versatile retroviral vectors for potential use in gene therapy.

Authors:  R G Hawley; F H Lieu; A Z Fong; T S Hawley
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

6.  Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death.

Authors:  V Sandig; K Brand; S Herwig; J Lukas; J Bartek; M Strauss
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

7.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Dominant negative MYC blocks transformation by ABL oncogenes.

Authors:  C L Sawyers; W Callahan; O N Witte
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.

Authors:  M A Kelliher; D J Weckstein; A G Knott; H H Wortis; N Rosenberg
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.

Authors:  C L Sawyers; J McLaughlin; O N Witte
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  4 in total

1.  Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatment.

Authors:  Tracy C Kuo; Joseph E Chavarria-Smith; Dan Huang; Mark S Schlissel
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

2.  Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.

Authors:  Christina Batsi; Soultana Markopoulou; Evangelos Kontargiris; Christiana Charalambous; Christoforos Thomas; Savvas Christoforidis; Panagiotis Kanavaros; Andreas I Constantinou; Kenneth B Marcu; Evangelos Kolettas
Journal:  Biochem Pharmacol       Date:  2009-03-27       Impact factor: 5.858

3.  Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Owen N Witte; Kenneth Dorshkind
Journal:  Genes Dev       Date:  2008-11-15       Impact factor: 11.361

4.  Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.

Authors:  Rebekah Stackpole Zimmerman; Naomi Rosenberg
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.